Trials / Sponsors / ZHOU FANGJIAN
ZHOU FANGJIAN
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma Renal Cell Carcinoma, Neoadjuvant | Phase 3 | 2023-04-19 |